Kissei Pharmaceutical Co (JP:4547) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kissei Pharmaceutical Co reported a 14.8% increase in net sales for the second quarter of Fiscal 2024, driven by its Pharmaceutical Business, despite a decline in operating profit due to rising R&D expenses. The company’s expansion of key and new products contributed significantly to the sales growth.
For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money